Using Immunotherapy to Treat Glioblastoma Most Aggressive Brain Cancer with Dr. Apostolos Stathopoulos ERC Immunotherapy

Apostolos Stathopoulos, CEO, ERC-Belgium talks about using immunotherapy to treat glioblastoma, the most malignant of all gliomas or brain cancers.  ERC's therapy, which stimulates the patient's immune system to mount an immune response against the tumor cells, has demonstrated a clinically meaningful survival benefit with minimal toxicity and unprecedented regressions of this deadly disease.

#ERC #immunotherapy #glioblastoma #cancer

ERC-Immunotherapy.com

Download the transcript here